It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...

Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.

The Dopamine Support Patch represents PatchMD’s commitment to addressing the growing demand for natural cognitive and mood ...

DUBLIN--(BUSINESS WIRE)--The "Global Transdermal Patches Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The global transdermal patches market is ...

The transdermal patches market is further segmented based on the patch type, adhesive type, application, distribution channel, end-user, and region. The Drug-In-Adhesives segment is expected to ...

Although antigen-specific autoimmunity is thought to play a critical role in the pathogenesis of multiple sclerosis, all currently available therapies reduce global immune function without targeting ...

Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.